**leukemia : In studies on the effectiveness of apigenin on the treatment of leukemia, scientists discovered how apigenin was able to induced natural cell death (apoptosis) in U937 human leukemia cells, exerting also anti-leukemic activity in vivo. It was also discovered that tumor growth in U937 xenografts was attenuated, something that raises the hopes for the medical industry to find proper ways to use this chemopreventive properties on the development of new medicines against leukemia.
**human myelogenous erythroleukamia and bladder carcinoma.The effects of various types of flavones, among them Apigenin and Luteolin, on two different cancer cell lines, including human chronic myelogenous erythroleukaemia (K562) and bladder carcinoma (RT112) were also part of other studies in the subject of flavones inhibitory properties on human tumor cancer cell lines. The results of one of this studies showed taht the cytotoxic effects of flavones (apigenin and luteolin) on the already mentioned cancer cell lines suggested that flavones Apigenin and Luteolin could be considered as potential chemotherapeutic agents.
**Cervical cancer : Apigenin didn’t just inhibit the cancer cells it caused them to commit cellular suicide (apoptosis)! The researchers concluded, “These findings suggest that apigenin has strong potential for development as an agent for preventing cervical cancer.
*Heart Disease : It is also well known that diets rich in flavones, as Apigenin, are very beneficial for our health, protecting it against cardiovascular disorders.
* neurological disease